Search results
Results from the Health.Zone Content Network
Ribavirin. Currently, the only FDA-approved drug for the treatment of active RSV infection is ribavirin. This medication is used only for people hospitalized with severe lower respiratory RSV ...
2 min read. Aug. 21, 2024 – The FDA has approved a new initial treatment for advanced non-small-cell lung cancer after clinical trials showed patients lived longer without disease progression ...
Use WebMD’s Pill Identifier to find and identify any over-the-counter or prescription drug, pill, or medication by color, shape, or imprint and easily compare pictures of multiple drugs.
Advaxis Inc. is an American company devoted to the discovery, development and commercialization of immunotherapies based on a technology platform which uses engineered Listeria monocytogenes (aka Lm). [1]: 1 The company is headquartered in Princeton, New Jersey and was incorporated in Delaware in 2006. [1]: 1
Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. [2] Actelion focuses on the manufacture of drugs that treat rare and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central ...
That’s what researchers at Apnimed hope. Apnimed is a company that’s developed a new oral drug for sleep apnea – currently called AD109. AD109 combines the drugs aroxybutynin and atomoxetine ...
Valoctocogene roxaparvovec is a gene therapy that uses an adeno-associated virus 5 (AAV5) that codes for human Factor VIII, together with a human liver-specific promoter that encourages translation in hepatocytes, not liver endothelial and sinusoidal cells, where Factor VIII is ordinarily synthesised.
By Puyaan Singh and Leroy Leo. (Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' liver disease treatment, Livdelzi, which it gained through a $4.3 billion ...